Comprehensive Analysis Reveals PTK6 as a Prognostic Biomarker Involved in the Immunosuppressive Microenvironment in Breast Cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comprehensive Analysis Reveals PTK6 as a Prognostic Biomarker Involved in the Immunosuppressive Microenvironment in Breast Cancer
Authors
Keywords
-
Journal
Journal of Immunology Research
Volume 2022, Issue -, Pages 1-14
Publisher
Hindawi Limited
Online
2022-11-10
DOI
10.1155/2022/5160705
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B Cell Function in the Tumor Microenvironment
- (2022) Stephanie M. Downs-Canner et al. Annual Review of Immunology
- Targeting the RNA m6A modification for cancer immunotherapy
- (2022) Xinxin Li et al. Molecular Cancer
- Interference of PTK6/GAB1 signaling inhibits cell proliferation, invasion, and migration of cervical cancer cells
- (2022) Juan Li et al. Molecular Medicine Reports
- Rethinking immune checkpoint blockade: ‘Beyond the T cell’
- (2021) Xiuting Liu et al. Journal for ImmunoTherapy of Cancer
- Effects of Baduanjin on postoperative rehabilitation of patients with breast cancer
- (2021) Guangyan Chen et al. MEDICINE
- Therapeutic Targeting of the Tumor Microenvironment
- (2021) Leire Bejarano et al. Cancer Discovery
- Innovations in cancer immunotherapy: chimeric antigen receptor T-cell therapy (CAR-T)
- (2021) Kevin Brown et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Pharmacological targeting PTK6 inhibits the JAK2/STAT3 sustained stemness and reverses chemoresistance of colorectal cancer
- (2021) Chaoqun Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Review of Breast Cancer Pathologigcal Image Processing
- (2021) Ya-nan Zhang et al. Biomed Research International
- Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
- (2021) Golnaz Morad et al. CELL
- Prevalence and mutational determinants of high tumor mutation burden in breast cancer
- (2020) R. Barroso-Sousa et al. ANNALS OF ONCOLOGY
- A review of cancer immunotherapy toxicity
- (2020) Lucy Boyce Kennedy et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Role of Immunotherapy in Triple-Negative Breast Cancer
- (2020) Tanya E. Keenan et al. Journal of the National Comprehensive Cancer Network
- The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
- (2020) Florent Petitprez et al. Frontiers in Immunology
- The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
- (2020) Yuanyuan Zhang et al. Cellular & Molecular Immunology
- Strategic Developments & Future Perspective on Gene therapy of Breast Cancer: Role of mTOR and Brk/ PTK6 as Molecular Targets
- (2020) Roja Sahu et al. CURRENT GENE THERAPY
- The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker
- (2020) Denis L. Jardim et al. CANCER CELL
- Beyond the tumour microenvironment
- (2019) Lucie Laplane et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cells
- (2019) Patrice Cagle et al. Scientific Reports
- NK Cell Metabolism and Tumor Microenvironment
- (2019) Iñigo Terrén et al. Frontiers in Immunology
- Diagnosis and Treatment of Breast Cancer in Young Women
- (2019) Lorenzo Rossi et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Decreased expression of protein tyrosine kinase 6 contributes to tumor progression and metastasis in laryngeal squamous cell carcinoma
- (2018) Di Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Endocrine side effects of cancer immunotherapy
- (2017) Priscilla Cukier et al. ENDOCRINE-RELATED CANCER
- Overexpression of PTK6 predicts poor prognosis in bladder cancer patients
- (2017) Xue-lian Xu et al. Journal of Cancer
- Molecular Imaging of Immunotherapy Targets in Cancer
- (2016) E. B. Ehlerding et al. JOURNAL OF NUCLEAR MEDICINE
- Bioinformatics for cancer immunotherapy target discovery
- (2014) Lars Rønn Olsen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Context-specific protein tyrosine kinase 6 (PTK6) signalling in prostate cancer
- (2013) Yu Zheng et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Breast Cancer
- (2013) Cindy B. Matsen et al. JAMA Surgery
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
- (2012) Guangchuang Yu et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Detection of Brk expression in non-small cell lung cancer: clinicopathological relevance
- (2011) Chuifeng Fan et al. TUMOR BIOLOGY
- Mechanisms of HGF/Met Signaling to Brk and Sam68 in Breast Cancer Progression
- (2011) Alessia Locatelli et al. Hormones & Cancer
- Brk/PTK6 signaling in normal and cancer cell models
- (2010) Julie H Ostrander et al. CURRENT OPINION IN PHARMACOLOGY
- PTK6 Regulates IGF-1-Induced Anchorage-Independent Survival
- (2010) Hanna Y. Irie et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started